GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alto Neuroscience Inc (NYSE:ANRO) » Definitions » Cash From Other Investing Activities

Alto Neuroscience (Alto Neuroscience) Cash From Other Investing Activities : $0.00 Mil (TTM As of Mar. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Alto Neuroscience Cash From Other Investing Activities?

Cash from other investing activities means the cash received by a company that comes from other investing activities.

Alto Neuroscience's cash from other investing activities for the three months ended in Mar. 2024 was $0.00 Mil. It means Alto Neuroscience received $0.00 Mil from other investing activities. Alto Neuroscience's cash from other investing activities for the trailing twelve months (TTM) ended in Mar. 2024 was $0.00 Mil.

Alto Neuroscience Cash From Other Investing Activities Historical Data

The historical data trend for Alto Neuroscience's Cash From Other Investing Activities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alto Neuroscience Cash From Other Investing Activities Chart

Alto Neuroscience Annual Data
Trend Dec21 Dec22 Dec23
Cash From Other Investing Activities
- - -

Alto Neuroscience Quarterly Data
Dec21 Sep22 Dec22 Mar23 Sep23 Dec23 Mar24
Cash From Other Investing Activities Get a 7-Day Free Trial - - - - -

Alto Neuroscience Cash From Other Investing Activities Calculation

Cash from other investing activities means the cash received by a company that comes from other investing activities.

Cash From Other Investing Activities for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alto Neuroscience Cash From Other Investing Activities Related Terms

Thank you for viewing the detailed overview of Alto Neuroscience's Cash From Other Investing Activities provided by GuruFocus.com. Please click on the following links to see related term pages.

Alto Neuroscience (Alto Neuroscience) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alto Neuroscience Inc (NYSE:ANRO) » Definitions » Cash From Other Investing Activities
Comparable Companies
Traded in Other Exchanges
N/A
Address
Website
Alto Neuroscience Inc is a clinical stage biopharmaceutical company with a mission to redefine psychiatry by leveraging individuals' neurobiology to develop personalized and highly effective treatment options. the company currently consists of five clinical-stage assets initially targeting major depressive disorder and schizophrenia populations as identified by independent brain-based biomarkers.

Alto Neuroscience (Alto Neuroscience) Headlines

From GuruFocus

Steven Cohen's Point72 Asset Management Buys New Stake in Alto Neuroscience Inc

By GuruFocus Research • 02-08-2024